Access to Medicine Index homepage

Key Finding - 20 Nov 2018

2018 Index finds progress being led by a handful of companies, including in pricing and R&D

The 2018 Access to Medicine Index finds that the pharmaceutical industry continues to mature in its approach to access to medicine with models for good practice in areas such as access planning and licensing.

6th Access to Medicine Index: latest analysis of pharma action.

The Index reports how 20 pharmaceutical companies make medicines, vaccines and diagnostics more accessible for people in low- and middle-income countries.

"There have been massive improvements in global health in the past decades, with all major pharmaceutical companies taking action. To close the gaps that remain, a greater diversity of companies must get involved and stay engaged."

Jayasree K. Iyer

Executive Director Access to Medicine Foundation

View our media coverage

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |